Professional Documents
Culture Documents
myocarditis.
Any information contained in this pdf file is automatically generated from digital material
submitted to EPOS by third parties in the form of scientific presentations. References
to any names, marks, products, or services of third parties or hypertext links to third-
party sites or information are provided solely as a convenience to you and do not in any
way constitute or imply RANZCR's endorsement, sponsorship or recommendation of the
third party, information, product or service. RANZCR is not responsible for the content of
these pages and does not make any representations regarding the content or accuracy
of material in this file.
As per copyright regulations, any unauthorised use of the material or parts thereof as
well as commercial reproduction or multiple distribution by any traditional or electronically
based reproduction/publication method ist strictly prohibited.
You agree to defend, indemnify, and hold RANZCR harmless from and against any
and all claims, damages, costs, and expenses, including attorneys' fees, arising from or
related to your use of these pages.
Please note: Links to movies, .ppt slideshows, .doc documents and any other multimedia
files are not available in the pdf version of presentations.
www.ranzcr.edu.au
Page 1 of 10
Learning Objectives
Background
Clinical presentation:
Often the symptomatology is non-specific, for example, fatigue, chest pain, palpitations,
shortness of breath.
Diagnosis:
•Traditionally Endomyocardial Biopsy (EMB) has been considered the gold standard in
the diagnosis of myocarditis.
i.e. EMB is usually performed at the right or inferior ventricular walls as they are more
accessible and less prone to complications however typical changes of myocarditis are
seen along the LV wall. Hence EMB has low sensitivity due to 'sampling error'. Hence
imaging is crucial
Page 2 of 10
•However its validity for the diagnosis of myocarditis has not been fully established. While
in routine clinical use for this purpose in some centres, CMR has not been established
as a valid diagnostic tool for myocarditis to a high degree.
2
•Small single centre publications have shown a high positive predictive value .
Methods:
•The pathology information system of Royal Perth Hospital was mined for the
histopathology results of any patient who had undergone an endomyocardial biopsy
(EMB) between 2004-2012.
•The cardiac MRI features of these patients were reviewed by two subspeciality
radiologists. Studies were retrospectively scored.
•Atypical pattern was any other form of enhancement, apart from recognised normal
myocardial DHE such as the fibrous core.
Results:
•Of these, 7 had undergone a pre-procedural cardiac MRI for the purpose of diagnosis
of myocarditis and guidance for the EMB procedure.
•The typical pattern of delayed hyperenhancement was observed in 70% (5/7) subjects
while 30% (2/7) had atypical pattern
Page 3 of 10
Fig. 1: Short axis view post Gadolinium (Gad) administration, typical subepicardial (SE),
inferolateral wall delayed hyperenhancement (DHE)
Page 4 of 10
Fig. 2: Four-chamber view post Gad-administration demonstrates nodular Subepicardial
delayed hyperenhancement along the lateral wall
Page 5 of 10
Fig. 3: Two-chamber view, typical Subepicardial infero-lateral wall DHE
Page 6 of 10
Fig. 4: Four-chamber view post Gad-administration demonstrates typical nodular
Subepicardial DHE along the lateral and septal walls
Page 7 of 10
Fig. 5: Two-chamber view in the same patient demonstrating subepicardial DHE.
Page 8 of 10
Fig. 6: Horizontal four-chamber view demonstrating atypical patchy fine nodular DHE
along the lateral and septal walls.
Page 9 of 10
Conclusion
Personal Information
References
Page 10 of 10